Discovery & translation
Novel targets, human-relevant models and translational strategies designed to improve confidence before entering the clinic.
April 5–6, 2027 • Amsterdam
Agenda
A focused scientific programme for the people advancing pain therapeutics from discovery to patients.
2027 programme in development
Help shape the next conversation
The detailed agenda will be released as sessions and speakers are confirmed. Register your interest to receive programme announcements.
Themes for 2027
What the programme will explore
Clinical development
Trial design, endpoints, biomarkers and patient-selection approaches that can produce clearer evidence in pain studies.
The evolving treatment landscape
Non-opioid innovation, responsible opioid development and the scientific, regulatory and commercial questions shaping access.
The 2026 agenda
A feel for the discussions we bring together
Last year’s programme brought scientific, clinical and industry leaders together around the decisions that matter across the pain-therapeutics lifecycle.
View the complete 2026 agenda- 01
New Approach Methodologies (NAMs) to improve success in pain R&D
- 02
Novel non-opioid analgesics and emerging mechanisms
- 03
Nav channel target validation and human nociceptor testing
- 04
Placebo-response mitigation and procedural integrity
- 05
Artificial intelligence in clinical trial optimization
- 06
Making better early decisions in pain drug development